thyssenkrupp nucera AG & Co. KGaA

Latest Results (14.10.2025):

In the latest fiscal year 2023/24, thyssenkrupp nucera AG & Co. KGaA demonstrated robust financial performance with total sales reaching €862 million. The company maintained a strong balance sheet, supported by a significant order backlog in both Green Hydrogen and Chlor-Alkali segments, positioning it well for future growth and sustainable industrial transformation.

Sales Growth

thyssenkrupp nucera AG & Co. KGaA reported total sales of €862 million for FY 2023/24, marking a substantial increase from previous years. This growth was driven by successful execution in both Green Hydrogen and Chlor-Alkali business segments.

Order Backlog

The company secured a strong order backlog of approximately €1 billion across its Green Hydrogen and Chlor-Alkali divisions. This robust pipeline underscores the market demand and the company's capability to deliver large-scale, environmentally friendly projects.

Profitability and Balance Sheet

Despite a temporary EBIT loss due to the ramp-up of Alkaline Water Electrolysis (AWE) operations, thyssenkrupp nucera AG & Co. KGaA remains resilient with a strong balance sheet. The company's financial strategy ensures adequate resources to withstand current operational challenges and finance future growth initiatives.

Strategic Investments

The company continues to invest in cutting-edge technologies and expanding its service offerings. Ongoing developments in high-efficiency electrolysis and the automation of cell production are expected to enhance operational efficiency and drive long-term profitability.

Global Presence

With over 10 locations worldwide and more than 1,000 climate model employees, thyssenkrupp nucera AG & Co. KGaA leverages its global network to support customers and deliver projects at an industrial scale, reinforcing its position as a leader in sustainable industrial solutions.